These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8438330)

  • 1. In vitro and in vivo activities of long-term cultured veto suppressor clones.
    Yanagie H; Takeda Y; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):350-1. PubMed ID: 8438330
    [No Abstract]   [Full Text] [Related]  

  • 2. Cloned veto cells as immunoregulators.
    Takeda Y; Yanagie H; Maki T
    Transplant Proc; 1993 Aug; 25(4):2743-4. PubMed ID: 8356732
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of mouse skin allograft survival by cloned veto suppressor cells.
    Takahashi T; Maki T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):192-3. PubMed ID: 1824972
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
    [No Abstract]   [Full Text] [Related]  

  • 5. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient.
    Zheng SG; Meng L; Wang JH; Watanabe M; Barr ML; Cramer DV; Gray JD; Horwitz DA
    Int Immunol; 2006 Feb; 18(2):279-89. PubMed ID: 16415106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of fully mismatched cardiac allografts and generation of regulatory cells by Sairei-to, a Japanese herbal medicine.
    Zhang Q; Iwami D; Aramaki O; Yakubo S; Nishimura K; Ishige A; Watanabe K; Matsuno K; Shirasugi N; Niimi M
    Transplantation; 2009 Jun; 87(12):1787-91. PubMed ID: 19543054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the in vivo cytotoxic T lymphocy te response with heat-treated allogeneic cells.
    Chiu KM; Faanes RB; Choi YS
    Transplantation; 1980 Feb; 29(2):159-60. PubMed ID: 6444472
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival.
    Xiang J; Gu X; Qian S; Chen Z
    Transpl Int; 2008 Feb; 21(2):163-8. PubMed ID: 17971032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I antigen pretreatment prolongs allograft survival in mice by induction of suppressor cells.
    Superina RA; Wood KJ; Morris PJ
    Transplant Proc; 1987 Aug; 19(4):3459-60. PubMed ID: 2956744
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
    Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of CD25- regulatory T cells following heart transplantation: evidence for transfer of long-term survival.
    Degauque N; Lair D; Braudeau C; Haspot F; Sébille F; Dupont A; Merieau E; Brouard S; Soulillou JP
    Eur J Immunol; 2007 Jan; 37(1):147-56. PubMed ID: 17171754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.